Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146532 · ClinicalTrials.gov registry record · Early Phase 1
Aspirin Effects on Emotional Reactions
A Early Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 268
- Enrollment target
NCT04146532 is a Early Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 268 participants.
The verdict
NCT04146532, a Early Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 268 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.
Interventions
- DRUG Placebo
- DRUG Aspirin 500 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2022-04-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04146532
The ClinicalTrials.gov registry entry for NCT04146532 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04146532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04146532 about?
NCT04146532 is a clinical study titled "Aspirin Effects on Emotional Reactions". The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.
What is the current status of trial NCT04146532?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 268 participants. The study started on 2019-10-08. Estimated completion is 2022-04-15.
What interventions are being tested in trial NCT04146532?
The interventions under investigation include: Placebo (DRUG), Aspirin 500 MG (DRUG).
Who is sponsoring clinical trial NCT04146532?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.